Bradford Cross

ThoughtWorks, Inc. provides systems integration and application development services. It offers system architecture, consulting, organizational transformation, software development, and implementation services. The firm serves energy, manufacturing, retail, and financial sectors. The company was founded by Neville Roy Singham in 1993 and is headquartered in Chicago, IL.

FlightCaster, Inc. provides information about flight delays. The firm uses an advanced algorithm that scours data on every domestic flight and matches it to real-time conditions. The company was founded by Evan Konwiser in July 2009 and is headquartered in San Francisco, CA.

O'Higgins Asset Management, Inc. is an American financial management company that was established in 1978. The private company provides investment approach and financial planning services to its clients.

DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California.

Woven, Inc. was engaged in online application platform that allows its users to create a newsfeed. The company was founded by Aria D. Haghighi and Bradford Cross on March 24, 2011 and was headquartered in San Francisco, CA.

Merlon Intelligence, Inc. develops software platform that can reduces compliance costs. The company was founded by Bradford Cross in 2016 and is headquartered in San Francisco, CA.

Prismatic Ltd. manufactures aerospace and defense products. Its products include PHASA-35, PHASE-8, LASA-5. The company was founded by Paul Brooks and is headquartered in Alton, the United Kingdom.

Part of Mind Medicine (MindMed), Inc., HealthMode, Inc. drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. The private company is based in San Francisco, CA. HealthMode's measurement techniques improve understanding of phenotype, streamline and provide assurance for screening and eligibility, provide early detection and mitigation of adverse events, and serve as sensitive, specific, objective, and low participant burden efficacy endpoints. These measurements allow for meaningful integration of clinical trial data with real-world evidence, and provide the basis for movement toward patient-specific measures. Better measurement tools and the platforms to support them help HealthMode's partners make data-informed decisions, reduce uncertainty around enrollment and outcomes, de-risk development, and increase the speed at which novel therapeutics reach patients in need. The company was founded by Bradford Cross, Daniel R. Karlin. HealthMode was acquired by Mind Medicine (MindMed), Inc. on February 26, 2021 for $41.54 million.